glaxosmithkline pharmaceuticals ltd share price
Average price decline of -2.49% within 7 days of Bearish signal in last 5 years, Average price decline of -2.33% within 7 days of Bearish signal in last 5 years, Average price decline of -2.11% within 7 days of Bearish signal in last 5 years, Average price decline of -3.23% within 30 days of Bearish signal in last 5 years, Average price decline of -4.88% within 30 days of Bearish signal in last 5 years, Average price decline of -2.18% within 7 days of Bearish signal in last 5 years, Average price gain of 6.13% within 7 weeks of Bullish signal in last 10 years, GlaxoSmithKline Pharmaceuticals Ltd., incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 24,575.73 Crore) operating in Pharmaceuticals sector. The dividend declared by a company is usually declared as a percentage of face value. Sun Pharma, Dr Reddy's, Aurobindo recall products in the US market, Announcement under Regulation 30 (LODR)-Newspaper Publication, Announcement under Regulation 30 (LODR)-Press Release / Media Release, No stock recommendations available for this stock, All figures in Rs Cr, unless mentioned otherwise, Company has used Rs 56.84 cr for investing activities which is an YoY decrease of 62.96%. Get live share price chart, key metrics, forecast and ratings of GlaxoSmithKline Pharmaceuticals Ltd - GLAXO on Tickertape Check out stock performance, F&O Quotes, historical chart, market capitalisastion, dividends, financial news and company news with … GlaxoSmithKline Pharmaceuticals Ltd. stock last traded price … View the latest GlaxoSmithKline Pharmaceuticals Ltd. (500660) stock price, news, historical charts, analyst ratings and financial information from WSJ. DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price. For the quarter ended 31-12-2020, the company has reported a Consolidated Total Income of Rs 871.22 Crore, down 1.93 % from last quarter Total Income of Rs 888.36 Crore and up 9.58 % from last year same quarter Total Income of Rs 795.09 Crore. All timestamps are reflected in IST (Indian Standard Time). RSS feed is a XML file that provides summaries, including links to the full versions of the content.It is available through RSS feed reader or through some browsers. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions. Glaxosmithkline Pharmaceuticals Ltd Live BSE Share Price today, Glaxo latest news, 500660 announcements. See fundamentals, technicals, peer comparison, shareholding … (Source: Consolidated Financials). Peer Name Market Cap. Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. ICICI Prudential Smallcap Fund Direct Plan-Growt.. ICICI Prudential Credit Risk Fund Direct Plan-Gr.. ICICI Prudential Asset Allocator Fund (FOF) Dire.. ICICI Prudential Balanced Advantage Direct-Growt.. ICICI Prudential Midcap Direct Plan-Growth. Company has Deloitte Haskins & Sells LLP as its auditors. GlaxoSmithKline Pharmaceuticals Ltd. stock last traded price is 1,450.70, GlaxoSmithKline Pharmaceuticals Ltd. share price moved down by -1.48% from its previous close of Rs 1,472.90. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2020.For the quarter ended 31-12-2020, the company has reported a Consolidated Total Income of Rs 871.22 Crore, down 1.93 % from last quarter Total Income of Rs 888.36 Crore and up 9.58 % from last year same quarter Total Income of Rs 795.09 Crore. Its today's share price is 1500.55. (Source: Consolidated Financials), Stock gave a 3 year return of 26.73% as compared to Nifty Midcap 100 which gave a return of 26.21%. Share Price, Corporate Actions, Valuation, Research Report, Financials and more - complete track record of Glaxosmithkline Pharmaceuticals Ltd.. From India's independent mutual fund research house The GlaxoSmithKline Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is 51.95.The shares are currently trading at ₹1554.. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time. Download any online RSS reader of your choice. The Indian healthcare sector is expected to reach US$ 372 billion by 2022, … Tomorrow is different. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today. GlaxoSmithKline Pharmaceuticals Ltd. share price forecast The 4 reports from 2 analysts offering long term price targets for GlaxoSmithKline Pharmaceuticals Ltd. have an average target of 1352.00. The consensus estimate represents a downside of -9.87% from the last price … For reprint rights: GlaxoSmithKline Pharmaceuticals Ltd., incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 24,575.73 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. share price moved down by -1.88 % from its previous close of Rs 1,500.10. Glaxosmithkline Pharmaceuticals Ltd Share Price in NSE and BSE. Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. The company’s top management includes Ms.R S karnad, Mr.P V Bhide, Mr.S Williams, Ms.P Thakur, Mr.D Sundaram, Mr.A N Roy, Mr.R Krishnaswamy, Mr.N Kaviratne, Mr.Sridhar Venkatesh, Dr.(Ms.)S Maheshwari. It will show you what's new since the last time you checked the feed, without having to visit the website. Strength - Analyse stocks based on their strengths, weakness, opportunities, and threats. Book Value Per Share … The Prices page of GlaxoSmithKline Pharmaceuticals Ltd.. captures the … Bullish / Bearish signals for GlaxoSmithKline Pharmaceuticals Ltd. basis selected technical indicators and moving average crossovers. Historical Prices Daily Activity ; Historical Indices ; Historical Prices ; Announcements ... GLAXO - Glaxosmithkline (Pak) Ltd. PHARMACEUTICALS. GlaxoSmithKline Pharmaceuticals Ltd (GLAXO:NSI) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. (as of last trading session), Stock generated 26.73% return as compared to Nifty Pharma which gave investors 39.85% return over 3 year time period. GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in London, England. Its today's share price is 1439.85. Its current market capitalisation stands at Rs 24475.78 Cr. 50 per equity shares 2015 -GlaxoSmithKline Pharmaceuticals Ltd. (`GSK India') announces completion of its transaction with Novartis Healthcare Pvt. Rs. It is a subsidiary of GlaxoSmithKline plc UK one of the world's leading research-based pharmaceutical and … By using this site, you agree to the Terms of Service and Privacy Policy. The PE ratio (or price-to-earnings ratio) is the one of … Date Opening price Closing price Minimum price Maximum price Change; GlaxoSmithkline Pharmaceuticals Ltd Stock Price Forecast for 2021: April 2021: Open: 1513.080 Close: 1535.390 Min: 1513.080 Max: 1538.830 Change: 1.45 % GlaxoSmithkline Pharmaceuticals Ltd Stock Price … Glaxosmithkline Pharmaceuticals Ltd. was incorporated in the year 1924. Ltd… Glaxosmithkline Pharmaceuticals Ltd. Stock/Share prices today, Glaxosmithkline Pharmaceuticals Ltd. Live BSE/NSE. {{HLdata.Fifty2WkHigh_adj|number:2}}{{HLdata.Fifty2WkHigh_adjDt}}, {{HLdata.Fifty2WkLow_adj|number:2}}{{HLdata.Fifty2WkLow_adjDt}}, If you have RSS reader, Please Cut and Paste the URL. All other things being equal, higher the dividend yield of the stock, the better it is for investors. Get details on Glaxosmithkline Pharmaceuticals Ltd. news, dividends, financial report, … Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters. Higher the market capitalization of a company, higher the rank it is assigned. Show More, Nifty 500, S&P BSE 500, Nifty MNC, + 16 more, Dr. Annie Besant Road,Worli,Mumbai, Maharashtra - 400030, GlaxoSmithKline Pharmaceuticals Ltd. share price moved down by -1.44% from its previous close of Rs 1,471.90. Glaxosmithkline Phar Stock Price Analysis and Quick Research Report. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company according to Forbes as of 2019, after Pfizer, Novartis, Roche, Sanofi, and Merck & Co. GSK … Stock analysis for GlaxoSmithKline Pharmaceuticals Ltd (GLXO:Natl India) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Copyright © 2021 Bennett, Coleman & Co. Ltd. All rights reserved. Book value is also known as Net Asset Value of a company. NSE BSE Glaxosmithkline Pharmaceuticals Ltd. This is a ratio of market capitalisation of a company’s stock to its annual sales. Note: Close price will be updated after 18.15 hrs on account of joint press release dated February 09, 2018 (joint press release) On Ex-Date, the % change is calculated with respect to Adjusted price … GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2020. Glaxo financial results, Glaxo shareholding, Glaxo annual reports, Glaxo pledge, Glaxo … The market capitalization here is taken for the fully paid-up equity share of the company. This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. This represents the 52 week high and low price of the security. This is the ranking of a company within its sector based on MCap or Market capitalization. On dividing this value with the total number of shares outstanding for the company, we can arrive at book value per share. Check Glaxosmithkline Pharmaceuticals Ltd's Live BSE/NSE prices with Historic … Company has Deloitte Haskins & Sells LLP as its auditors. Perform Fundamental Analysis of GLAXOSMITHKLINE PHARMACEUTICALS LTD without wasting time ... SHARE PRICE MOMENTUM OF GLAXOSMITHKLINE PHARMACEUTICALS LTD. Weekly Trend . DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. Share. GlaxoSmithKline Pharmaceuticals up by 0.00% is trading at ₹ 1,471.90 today. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. GlaxoSmithKline Pharmaceuticals Ltd.-GLAXO, BSE:500660 Latest news, stock scores, research reports and price movements. {{HeaderData[0].chg}} {{HeaderData[0].perchg}}%. As on 31-12-2020, the company has a total of 16.94 Crore shares outstanding. Is Glaxosmithkline Phar an attractive stock to invest in? RSS stands for Really Simple Syndication. The Night of Ideas: 24 Hours Live to Feel "Closer", The Economic Times Digital Payments Forum, Closing Cash & Cash Equivalent Growth (%), Bonus Ratio: 1 share(s) for every 1 shares held, Rights ratio: 1 share for every 5 held at a price of Rs 65.0, Bonus Ratio: 1 share(s) for every 3 shares held. DEBT. GlaxoSmithKline Pharmaceuticals Ltd is one of the leading pharmaceutical companies in the India. Its current market capitalisation stands at Rs 25420.22 Cr. It is also the 1 year high and low of the security. GlaxoSmithKline Pharmaceuticals Limited: 26,178: Abbott India Limited: 31,362: Sanofi India Limited: 18,972: Panacea Biotec Limited: 1,203 Get GlaxoSmithKline Pharmaceuticals Ltd. live share price, historical charts, volume, market capitalisation, market performance, reports and other company details. Volume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point. SWOT analysis is a powerful tool for understanding a company’s market position. 150.28 ... Enterprise Value Per Share Upto 2020 3Q . Price to Book represents the ratio of current market price of a stock to its book value per share. … Company has reported net profit after tax of Rs 156.51 Crore in latest quarter.The company’s top management includes Ms.R S karnad, Mr.P V Bhide, Mr.S Williams, Ms.P Thakur, Mr.D Sundaram, Mr.A N Roy, Mr.R Krishnaswamy, Mr.N Kaviratne, Mr.Sridhar Venkatesh, Dr.(Ms.)S Maheshwari. It includes Glaxosmithkline Pharma Stock Price Details like live share price, day's high & low, 6 month & 1 year return & more. Glaxosmithkline Pharmaceuticals Ltd. was incorporated in the year 1924. Let's reshape it today, Hunt for the brightest engineers in India, Company has spent less than 1% of its operating revenues towards interest expenses and 19.49% towards employee cost in the year ending Mar 31, 2020. Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. Glaxosmithkline Pharmaceuticals Ltd Share Price- Get Glaxosmithkline Pharmaceuticals Ltd Stock/Share prices. As on 31-12-2020, the company has a total of 16.94 Crore shares outstanding. 2014 -GlaxoSmithKline Pharmaceuticals Ltd. has recommended a Dividend of Rs. Glaxosmithkline Pharmaceuticals live stock/share price, Growth & Valuation Rating, Quarterly Results, financial ratio, balance sheet, annual/profit & loss result, news, shareholding, Investor Learn about Glaxosmithkline Pharmaceuticals Ltd. share price, trend signals, stock returns, and & company details and decide whether to invest in Glaxosmithkline Pharmaceuticals Ltd. stocks. GlaxoSmithKline Pharmaceuticals Ltd. stock last traded price is 1,451.10. Book value represents the value arrived at by subtracting the total liabilities from the total assets of the company. Here we have taken the TTM (trailing twelve months) adjusted earnings per share. GSK Pharma Share Price Update. (as of last trading session). Company has reported net profit after tax of Rs 156.51 Crore in latest quarter.